Global Drugs for Non-small Cell Lung Cancer Market Size, Status and Forecast 2025

January 2018 | 114 pages | ID: G8302760540EN
QYResearch

Abstracts

This report studies the global Drugs for Non-small Cell Lung Cancer market, analyzes and researches the Drugs for Non-small Cell Lung Cancer development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like

• Bristol-Myers Squibb
• GlaxoSmithKline
• Menarini
• Sanofi
• Ziopharm Oncology
• Alchemia
• Amgen
• Apotex
• BioMarin Pharmaceutical
• CellAct Pharma
• Cerulean Pharma
• Cipla
• Cornerstone Pharmaceuticals
• Curis
• CytRx
• Eli Lilly
• Exelixis
• Fresenius Kabi
• Genentech
• Hikma Pharmaceuticals
• Hospira
• Intas Pharmaceuticals
• Karyopharm Therapeutics
• Kyowa Hakko Kirin
• Ligand Pharmaceuticals

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, the product can be split into

• Radiofrequency Ablation (RFA)
• Radiation Therapy
• Chemotherapy
• Targeted Therapies
• Immunotherapy

Market segment by Application, Drugs for Non-small Cell Lung Cancer can be split into

• Hospitals
• Clinics
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Drugs for Non-small Cell Lung Cancer Market Size, Status and Forecast 2025

1 INDUSTRY OVERVIEW OF DRUGS FOR NON-SMALL CELL LUNG CANCER

1.1 Drugs for Non-small Cell Lung Cancer Market Overview
  1.1.1 Drugs for Non-small Cell Lung Cancer Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Drugs for Non-small Cell Lung Cancer Market Size and Analysis by Regions (2013-2018)
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Drugs for Non-small Cell Lung Cancer Market by Type
  1.3.1 Radiofrequency Ablation (RFA)
  1.3.2 Radiation Therapy
  1.3.3 Chemotherapy
  1.3.4 Targeted Therapies
  1.3.5 Immunotherapy
1.4 Drugs for Non-small Cell Lung Cancer Market by End Users/Application
  1.4.1 Hospitals
  1.4.2 Clinics
  1.4.3 Other

2 GLOBAL DRUGS FOR NON-SMALL CELL LUNG CANCER COMPETITION ANALYSIS BY PLAYERS

2.1 Drugs for Non-small Cell Lung Cancer Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 Bristol-Myers Squibb
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Drugs for Non-small Cell Lung Cancer Revenue (Million USD) (2013-2018)
  3.1.5 Recent Developments
3.2 GlaxoSmithKline
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Drugs for Non-small Cell Lung Cancer Revenue (Million USD) (2013-2018)
  3.2.5 Recent Developments
3.3 Menarini
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Drugs for Non-small Cell Lung Cancer Revenue (Million USD) (2013-2018)
  3.3.5 Recent Developments
3.4 Sanofi
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Drugs for Non-small Cell Lung Cancer Revenue (Million USD) (2013-2018)
  3.4.5 Recent Developments
3.5 Ziopharm Oncology
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Drugs for Non-small Cell Lung Cancer Revenue (Million USD) (2013-2018)
  3.5.5 Recent Developments
3.6 Alchemia
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Drugs for Non-small Cell Lung Cancer Revenue (Million USD) (2013-2018)
  3.6.5 Recent Developments
3.7 Amgen
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Drugs for Non-small Cell Lung Cancer Revenue (Million USD) (2013-2018)
  3.7.5 Recent Developments
3.8 Apotex
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Drugs for Non-small Cell Lung Cancer Revenue (Million USD) (2013-2018)
  3.8.5 Recent Developments
3.9 BioMarin Pharmaceutical
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Drugs for Non-small Cell Lung Cancer Revenue (Million USD) (2013-2018)
  3.9.5 Recent Developments
3.10 CellAct Pharma
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 Drugs for Non-small Cell Lung Cancer Revenue (Million USD) (2013-2018)
  3.10.5 Recent Developments
3.11 Cerulean Pharma
3.12 Cipla
3.13 Cornerstone Pharmaceuticals
3.14 Curis
3.15 CytRx
3.16 Eli Lilly
3.17 Exelixis
3.18 Fresenius Kabi
3.19 Genentech
3.20 Hikma Pharmaceuticals
3.21 Hospira
3.22 Intas Pharmaceuticals
3.23 Karyopharm Therapeutics
3.24 Kyowa Hakko Kirin
3.25 Ligand Pharmaceuticals

4 GLOBAL DRUGS FOR NON-SMALL CELL LUNG CANCER MARKET SIZE BY TYPE AND APPLICATION (2013-2018)

4.1 Global Drugs for Non-small Cell Lung Cancer Market Size by Type (2013-2018)
4.2 Global Drugs for Non-small Cell Lung Cancer Market Size by Application (2013-2018)
4.3 Potential Application of Drugs for Non-small Cell Lung Cancer in Future
4.4 Top Consumer/End Users of Drugs for Non-small Cell Lung Cancer

5 UNITED STATES DRUGS FOR NON-SMALL CELL LUNG CANCER DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Drugs for Non-small Cell Lung Cancer Market Size (2013-2018)
5.2 United States Drugs for Non-small Cell Lung Cancer Market Size and Market Share by Players (2013-2018)
5.3 United States Drugs for Non-small Cell Lung Cancer Market Size by Application (2013-2018)

6 EU DRUGS FOR NON-SMALL CELL LUNG CANCER DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Drugs for Non-small Cell Lung Cancer Market Size (2013-2018)
6.2 EU Drugs for Non-small Cell Lung Cancer Market Size and Market Share by Players (2013-2018)
6.3 EU Drugs for Non-small Cell Lung Cancer Market Size by Application (2013-2018)

7 JAPAN DRUGS FOR NON-SMALL CELL LUNG CANCER DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Drugs for Non-small Cell Lung Cancer Market Size (2013-2018)
7.2 Japan Drugs for Non-small Cell Lung Cancer Market Size and Market Share by Players (2013-2018)
7.3 Japan Drugs for Non-small Cell Lung Cancer Market Size by Application (2013-2018)

8 CHINA DRUGS FOR NON-SMALL CELL LUNG CANCER DEVELOPMENT STATUS AND OUTLOOK

8.1 China Drugs for Non-small Cell Lung Cancer Market Size (2013-2018)
8.2 China Drugs for Non-small Cell Lung Cancer Market Size and Market Share by Players (2013-2018)
8.3 China Drugs for Non-small Cell Lung Cancer Market Size by Application (2013-2018)

9 INDIA DRUGS FOR NON-SMALL CELL LUNG CANCER DEVELOPMENT STATUS AND OUTLOOK

9.1 India Drugs for Non-small Cell Lung Cancer Market Size (2013-2018)
9.2 India Drugs for Non-small Cell Lung Cancer Market Size and Market Share by Players (2013-2018)
9.3 India Drugs for Non-small Cell Lung Cancer Market Size by Application (2013-2018)

10 SOUTHEAST ASIA DRUGS FOR NON-SMALL CELL LUNG CANCER DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Drugs for Non-small Cell Lung Cancer Market Size (2013-2018)
10.2 Southeast Asia Drugs for Non-small Cell Lung Cancer Market Size and Market Share by Players (2013-2018)
10.3 Southeast Asia Drugs for Non-small Cell Lung Cancer Market Size by Application (2013-2018)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2018-2025)

11.1 Global Drugs for Non-small Cell Lung Cancer Market Size (Value) by Regions (2018-2025)
  11.1.1 United States Drugs for Non-small Cell Lung Cancer Revenue and Growth Rate (2018-2025)
  11.1.2 EU Drugs for Non-small Cell Lung Cancer Revenue and Growth Rate (2018-2025)
  11.1.3 Japan Drugs for Non-small Cell Lung Cancer Revenue and Growth Rate (2018-2025)
  11.1.4 China Drugs for Non-small Cell Lung Cancer Revenue and Growth Rate (2018-2025)
  11.1.5 India Drugs for Non-small Cell Lung Cancer Revenue and Growth Rate (2018-2025)
  11.1.6 Southeast Asia Drugs for Non-small Cell Lung Cancer Revenue and Growth Rate (2018-2025)
11.2 Global Drugs for Non-small Cell Lung Cancer Market Size (Value) by Type (2018-2025)
11.3 Global Drugs for Non-small Cell Lung Cancer Market Size by Application (2018-2025)

12 DRUGS FOR NON-SMALL CELL LUNG CANCER MARKET DYNAMICS

12.1 Drugs for Non-small Cell Lung Cancer Market Opportunities
12.2 Drugs for Non-small Cell Lung Cancer Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Drugs for Non-small Cell Lung Cancer Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Drugs for Non-small Cell Lung Cancer Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global Drugs for Non-small Cell Lung Cancer Market Size (Million USD) Status and Outlook (2013-2018)
Table Global Drugs for Non-small Cell Lung Cancer Revenue (Million USD) Comparison by Regions (2013-2018)
Figure Global Drugs for Non-small Cell Lung Cancer Market Share by Regions (2013-2018)
Figure United States Drugs for Non-small Cell Lung Cancer Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure EU Drugs for Non-small Cell Lung Cancer Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Japan Drugs for Non-small Cell Lung Cancer Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure China Drugs for Non-small Cell Lung Cancer Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure India Drugs for Non-small Cell Lung Cancer Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Southeast Asia Drugs for Non-small Cell Lung Cancer Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table Global Drugs for Non-small Cell Lung Cancer Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
Figure Global Drugs for Non-small Cell Lung Cancer Revenue Market Share by Type in 2017
Figure Radiofrequency Ablation (RFA) Market Size (Million USD) and Growth Rate (2013-2018)
Figure Radiation Therapy Market Size (Million USD) and Growth Rate (2013-2018)
Figure Chemotherapy Market Size (Million USD) and Growth Rate (2013-2018)
Figure Targeted Therapies Market Size (Million USD) and Growth Rate (2013-2018)
Figure Immunotherapy Market Size (Million USD) and Growth Rate (2013-2018)
Figure Global Drugs for Non-small Cell Lung Cancer Market Share by Application in 2017
Figure Drugs for Non-small Cell Lung Cancer Market Size (Million USD) and Growth Rate in Hospitals (2013-2018)
Figure Drugs for Non-small Cell Lung Cancer Market Size (Million USD) and Growth Rate in Clinics (2013-2018)
Figure Drugs for Non-small Cell Lung Cancer Market Size (Million USD) and Growth Rate in Other (2013-2018)
Table Drugs for Non-small Cell Lung Cancer Market Size (Million USD) by Players (2013-2018)
Figure Drugs for Non-small Cell Lung Cancer Market Size Share by Players in 2013
Figure Drugs for Non-small Cell Lung Cancer Market Size Share by Players in 2017
Table Bristol-Myers Squibb Basic Information List
Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Bristol-Myers Squibb (2013-2018)
Figure Bristol-Myers Squibb Drugs for Non-small Cell Lung Cancer Business Revenue Market Share (2013-2018)
Table GlaxoSmithKline Basic Information List
Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of GlaxoSmithKline (2013-2018)
Figure GlaxoSmithKline Drugs for Non-small Cell Lung Cancer Business Revenue Market Share (2013-2018)
Table Menarini Basic Information List
Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Menarini (2013-2018)
Figure Menarini Drugs for Non-small Cell Lung Cancer Business Revenue Market Share (2013-2018)
Table Sanofi Basic Information List
Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Sanofi (2013-2018)
Figure Sanofi Drugs for Non-small Cell Lung Cancer Business Revenue Market Share (2013-2018)
Table Ziopharm Oncology Basic Information List
Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Ziopharm Oncology (2013-2018)
Figure Ziopharm Oncology Drugs for Non-small Cell Lung Cancer Business Revenue Market Share (2013-2018)
Table Alchemia Basic Information List
Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Alchemia (2013-2018)
Figure Alchemia Drugs for Non-small Cell Lung Cancer Business Revenue Market Share (2013-2018)
Table Amgen Basic Information List
Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Amgen (2013-2018)
Figure Amgen Drugs for Non-small Cell Lung Cancer Business Revenue Market Share (2013-2018)
Table Apotex Basic Information List
Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Apotex (2013-2018)
Figure Apotex Drugs for Non-small Cell Lung Cancer Business Revenue Market Share (2013-2018)
Table BioMarin Pharmaceutical Basic Information List
Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of BioMarin Pharmaceutical (2013-2018)
Figure BioMarin Pharmaceutical Drugs for Non-small Cell Lung Cancer Business Revenue Market Share (2013-2018)
Table CellAct Pharma Basic Information List
Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of CellAct Pharma (2013-2018)
Figure CellAct Pharma Drugs for Non-small Cell Lung Cancer Business Revenue Market Share (2013-2018)
Table Cerulean Pharma Basic Information List
Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Cerulean Pharma (2013-2018)
Figure Cerulean Pharma Drugs for Non-small Cell Lung Cancer Business Revenue Market Share (2013-2018)
Table Cipla Basic Information List
Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Cipla (2013-2018)
Figure Cipla Drugs for Non-small Cell Lung Cancer Business Revenue Market Share (2013-2018)
Table Cornerstone Pharmaceuticals Basic Information List
Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Cornerstone Pharmaceuticals (2013-2018)
Figure Cornerstone Pharmaceuticals Drugs for Non-small Cell Lung Cancer Business Revenue Market Share (2013-2018)
Table Curis Basic Information List
Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Curis (2013-2018)
Figure Curis Drugs for Non-small Cell Lung Cancer Business Revenue Market Share (2013-2018)
Table CytRx Basic Information List
Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of CytRx (2013-2018)
Figure CytRx Drugs for Non-small Cell Lung Cancer Business Revenue Market Share (2013-2018)
Table Eli Lilly Basic Information List
Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Eli Lilly (2013-2018)
Figure Eli Lilly Drugs for Non-small Cell Lung Cancer Business Revenue Market Share (2013-2018)
Table Exelixis Basic Information List
Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Exelixis (2013-2018)
Figure Exelixis Drugs for Non-small Cell Lung Cancer Business Revenue Market Share (2013-2018)
Table Fresenius Kabi Basic Information List
Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Fresenius Kabi (2013-2018)
Figure Fresenius Kabi Drugs for Non-small Cell Lung Cancer Business Revenue Market Share (2013-2018)
Table Genentech Basic Information List
Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Genentech (2013-2018)
Figure Genentech Drugs for Non-small Cell Lung Cancer Business Revenue Market Share (2013-2018)
Table Hikma Pharmaceuticals Basic Information List
Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Hikma Pharmaceuticals (2013-2018)
Figure Hikma Pharmaceuticals Drugs for Non-small Cell Lung Cancer Business Revenue Market Share (2013-2018)
Table Hospira Basic Information List
Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Hospira (2013-2018)
Figure Hospira Drugs for Non-small Cell Lung Cancer Business Revenue Market Share (2013-2018)
Table Intas Pharmaceuticals Basic Information List
Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Intas Pharmaceuticals (2013-2018)
Figure Intas Pharmaceuticals Drugs for Non-small Cell Lung Cancer Business Revenue Market Share (2013-2018)
Table Karyopharm Therapeutics Basic Information List
Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Karyopharm Therapeutics (2013-2018)
Figure Karyopharm Therapeutics Drugs for Non-small Cell Lung Cancer Business Revenue Market Share (2013-2018)
Table Kyowa Hakko Kirin Basic Information List
Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Kyowa Hakko Kirin (2013-2018)
Figure Kyowa Hakko Kirin Drugs for Non-small Cell Lung Cancer Business Revenue Market Share (2013-2018)
Table Ligand Pharmaceuticals Basic Information List
Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Ligand Pharmaceuticals (2013-2018)
Figure Ligand Pharmaceuticals Drugs for Non-small Cell Lung Cancer Business Revenue Market Share (2013-2018)
Table Global Drugs for Non-small Cell Lung Cancer Market Size (Million USD) by Product (2013-2018)
Figure Global Drugs for Non-small Cell Lung Cancer Revenue Market Share (%) by Product (2013-2018)
Figure Global Drugs for Non-small Cell Lung Cancer Market Share by Product in 2017
Table Global Drugs for Non-small Cell Lung Cancer Market Size by Application (2013-2018)
Figure Global Drugs for Non-small Cell Lung Cancer Revenue Market Share (%) by Application in 2017
Table Top Consumer/End Users of Drugs for Non-small Cell Lung Cancer
Figure United States Drugs for Non-small Cell Lung Cancer Market Size (Million USD) and Growth Rate (2013-2018)
Table United States Drugs for Non-small Cell Lung Cancer Market Size (Million USD) by Players (2013-2018)
Figure United States Drugs for Non-small Cell Lung Cancer Market Size Share by Players in 2013
Figure United States Drugs for Non-small Cell Lung Cancer Market Size Share by Players in 2017
Table United States Drugs for Non-small Cell Lung Cancer Market Size by Application (2013-2018)
Figure United States Drugs for Non-small Cell Lung Cancer Revenue Market Share (%) by Application (2013-2018)
Figure United States Drugs for Non-small Cell Lung Cancer Market Size Share by Application in 2017
Figure EU Drugs for Non-small Cell Lung Cancer Market Size (Million USD) and Growth Rate (2013-2018)
Table EU Drugs for Non-small Cell Lung Cancer Market Size (Million USD) by Players (2013-2018)
Figure EU Drugs for Non-small Cell Lung Cancer Market Size Share by Players in 2013
Figure EU Drugs for Non-small Cell Lung Cancer Market Size Share by Players in 2017
Table EU Drugs for Non-small Cell Lung Cancer Market Size by Application (2013-2018)
Figure EU Drugs for Non-small Cell Lung Cancer Revenue Market Share (%) by Application (2013-2018)
Figure EU Drugs for Non-small Cell Lung Cancer Market Size Share by Application in 2017
Figure Japan Drugs for Non-small Cell Lung Cancer Market Size (Million USD) and Growth Rate (2013-2018)
Table Japan Drugs for Non-small Cell Lung Cancer Market Size (Million USD) by Players (2013-2018)
Figure Japan Drugs for Non-small Cell Lung Cancer Market Size Share by Players in 2013
Figure Japan Drugs for Non-small Cell Lung Cancer Market Size Share by Players in 2017
Table Japan Drugs for Non-small Cell Lung Cancer Market Size by Application (2013-2018)
Figure Japan Drugs for Non-small Cell Lung Cancer Revenue Market Share (%) by Application (2013-2018)
Figure Japan Drugs for Non-small Cell Lung Cancer Market Size Share by Application in 2017
Figure China Drugs for Non-small Cell Lung Cancer Market Size (Million USD) and Growth Rate (2013-2018)
Table China Drugs for Non-small Cell Lung Cancer Market Size (Million USD) by Players (2013-2018)
Figure China Drugs for Non-small Cell Lung Cancer Market Size Share by Players in 2013
Figure China Drugs for Non-small Cell Lung Cancer Market Size Share by Players in 2017
Table China Drugs for Non-small Cell Lung Cancer Market Size by Application (2013-2018)
Figure China Drugs for Non-small Cell Lung Cancer Revenue Market Share (%) by Application (2013-2018)
Figure China Drugs for Non-small Cell Lung Cancer Market Size Share by Application in 2017
Figure India Drugs for Non-small Cell Lung Cancer Market Size (Million USD) and Growth Rate (2013-2018)
Table India Drugs for Non-small Cell Lung Cancer Market Size (Million USD) by Players (2013-2018)
Figure India Drugs for Non-small Cell Lung Cancer Market Size Share by Players in 2013
Figure India Drugs for Non-small Cell Lung Cancer Market Size Share by Players in 2017
Table India Drugs for Non-small Cell Lung Cancer Market Size by Application (2013-2018)
Figure India Drugs for Non-small Cell Lung Cancer Revenue Market Share (%) by Application (2013-2018)
Figure India Drugs for Non-small Cell Lung Cancer Market Size Share by Application in 2017
Figure Southeast Asia Drugs for Non-small Cell Lung Cancer Market Size (Million USD) and Growth Rate (2013-2018)
Table Southeast Asia Drugs for Non-small Cell Lung Cancer Market Size (Million USD) by Players (2013-2018)
Figure Southeast Asia Drugs for Non-small Cell Lung Cancer Market Size Share by Players in 2013
Figure Southeast Asia Drugs for Non-small Cell Lung Cancer Market Size Share by Players in 2017
Table Southeast Asia Drugs for Non-small Cell Lung Cancer Market Size by Application (2013-2018)
Figure Southeast Asia Drugs for Non-small Cell Lung Cancer Revenue Market Share (%) by Application (2013-2018)
Figure Southeast Asia Drugs for Non-small Cell Lung Cancer Market Size Share by Application in 2017
Figure Global Drugs for Non-small Cell Lung Cancer Market Size and Growth Rate (2018-2025)
Table Global Drugs for Non-small Cell Lung Cancer Market Size (Million USD) by Regions (2018-2025)
Figure Global Drugs for Non-small Cell Lung Cancer Market Size Share (2018-2025)
Figure Global Drugs for Non-small Cell Lung Cancer Market Size Share by Regions in 2025
Figure United States Drugs for Non-small Cell Lung Cancer Revenue (Million USD) and Growth Rate (2018-2025)
Figure EU Drugs for Non-small Cell Lung Cancer Revenue (Million USD) and Growth Rate (2018-2025)
Figure Japan Drugs for Non-small Cell Lung Cancer Revenue (Million USD) and Growth Rate (2018-2025)
Figure China Drugs for Non-small Cell Lung Cancer Revenue (Million USD) and Growth Rate (2018-2025)
Figure India Drugs for Non-small Cell Lung Cancer Revenue (Million USD) and Growth Rate (2018-2025)
Figure Southeast Asia Drugs for Non-small Cell Lung Cancer Revenue (Million USD) and Growth Rate (2018-2025)
Table Global Drugs for Non-small Cell Lung Cancer Market Size (Million USD) by Type (2018-2025)
Figure Global Drugs for Non-small Cell Lung Cancer Market Size Share by Type in 2018
Figure Global Drugs for Non-small Cell Lung Cancer Market Size Share by Type in 2025
Table Global Drugs for Non-small Cell Lung Cancer Market Size (Million USD) by Application (2018-2025)
Figure Global Drugs for Non-small Cell Lung Cancer Market Size (Million USD) by Application in 2018
Figure Global Drugs for Non-small Cell Lung Cancer Market Size (Million USD) by Application in 2025